Cancer vaccines have gained heaps of consideration as the longer term of most cancers remedy. However, poor immunogenicity of tumor-associated antigens typically fails to induce an environment friendly immune response towards the tumor. Strange anti-tumor immune responses on the parasite-infected sufferers attributable to cross-reactivity have been reported in varied research.
Therefore, parasite antigens with important immunogenicity and excessive epitope homology with most cancers antigens could activate a robust immune response towards most cancers cells. Herein, the sera of immunized rabbits with the hydatid cyst wall (HCW) antigens had been incubated with Four T1 mammary carcinoma cells to analyze cross-reactivity between the HCW antigens antisera and floor antigens of the breast most cancers cells.
Also, the SDS-PAGE profile of HCW antigens was ready and incubated with the breast most cancers sufferers’ sera and appreciable reactivity was noticed between their sera and a particular band (~27/28 kDa) in accordance with Western blotting analyzes. Then, the protein bands with cross-reactivity with breast most cancers sufferers’ sera had been utilized for prophylactic immunizations of Balb/c mice.
The immunoprotective impact of immunization with the HCW antigens precipitated important inhibition of Four T1 breast tumor progress, lower of metastasis, and enlargement of the tumor-bearing mice survival time in comparability with PBS and pure immune adjuvant injected teams.
Mass spectrometry evaluation confirmed that the ~ 27/28 kDa band has numbers of proteins/polypeptides with a excessive diploma of homology with most cancers cells antigens which could be the rationale for this cross-reactivity and anti-tumor immune response. Taking collectively, immunization with HCW antigens could be a promising method in most cancers immunotherapy after additional investigations.
A prokaryote system optimization for rMEPLox expression: A promising non-toxic antigen for Loxosceles antivenom manufacturing
Loxoscelism is probably the most harmful araneism type in Brazil and antivenom remedy is the advisable remedy. Antivenom is produced by horse immunization with Loxosceles spider venom, which is poisonous for the producer animal. Moreover, because of the excessive quantity of venom required for horse hyperimmunization, new methods for antigens obtention have been proposed.
In this sense, our analysis group has beforehand produced a non-toxic recombinant multiepitopic protein derived from Loxosceles toxins (rMEPLox). rMEPLox was a profitable immunogen, with the ability to induce the manufacturing of neutralizing antibodies, which could possibly be used in the Loxoscelism remedy. However, rMEPLox obtention process requires optimization, as its manufacturing must be scaled as much as go well with antivenom manufacture.
Therefore, an efficient protocol growth for rMEPlox manufacturing could be advantageous. To obtain this goal, we evaluated the affect of completely different cultivation situations for rMEPLox optimum expression. The optimum situations to acquire massive quantities of rMEPlox had been outlined because the use of C43(DE3)pLysS as a host pressure, 2xTY medium, 0.6 mM IPTG, biomass pre induction of OD600nm = 0.4 and incubation at 30 °C for 16 h.
Following the optimized protocol, 39.84 mg/L of soluble rMEPLox was obtained and examined as immunogen. The outcomes present that the obtained rMEPLox preserved the beforehand described immunogenicity, and it was capable of generate antibodies that acknowledge completely different epitopes of the primary Loxosceles venom toxins, which makes it a promising candidate for the antivenom manufacturing for loxoscelism remedy.
MWCNTs-CoP hybrids for dual-signal electrochemical immunosensing of carcinoembryonic antigen based mostly on general water splitting
Great efforts have been made to seek for extremely energetic catalysts towards electrochemical water splitting, however double-signal immunosensors haven’t been reported based mostly on bifunctional water splitting electrocatalysts. We report right here a dual-signal electrochemical immunosensor for detecting carcinoembryonic antigen (CEA) utilizing multi-wall carbon nanotubes (MWCNTs)-cobalt phosphide (CoP) as an electrocatalytic label.
The preparation of MWCNTs-CoP entails the expansion of Co3O4 nanoparticles on MWCNTs and low-temperature phosphatization of Co3O4 nanoparticles. The MWCNTs-CoP catalyst reveals glorious electrocatalytic actions in a impartial medium towards each hydrogen evolution response (HER) and oxygen evolution response (OER), enabling MWCNTs-CoP because the electrocatalytic label for delicate immunosensing.
The linear vary of the sandwich-type immunosensor for detecting CEA based mostly on the HER sign is from 10-4-100 ng mL-1, whereas a linear vary for detecting CEA based mostly on the OER sign is achieved from 10-4 to 10 ng mL-1. The detection limits for detecting CEA utilizing HER and OER alerts are 10 and 12 fg mL-1, respectively. This work can present a new double-signal immunosensing platform based mostly on a bifunctional water splitting electrocatalyst.
Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model
Emerging infectious ailments signify an growing menace to human and animal well being. Therefore, protected and efficient vaccines that could possibly be accessible inside a brief time-frame after an outbreak are required for ample prevention and management. Here, we developed a sturdy and versatile self-assembling multimeric protein scaffold particle (MPSP) vaccine platform utilizing lumazine synthase (LS) from Aquifex aeolicus.
This scaffold allowed the presentation of peptide epitopes by genetic fusion in addition to the presentation of massive antigens by bacterial superglue-based conjugation to the pre-assembled particle. Using the orthobunyavirus model Schmallenberg virus (SBV) we designed MPSPs presenting main immunogens of SBV and assessed their efficacy in a mouse model in addition to in cattle, a goal species of SBV.
Epstein Barr Virus, Early Antigen, zeta |
|||
| MBS600173-5x01mg | MyBiosource | 5x0.1mg | 2470 EUR |
Epstein Barr Virus (EBV) Nuclear Antigen |
|||
| BA1362VS | Genovis AB | 1mg | 1138 EUR |
Epstein Barr Virus (EBV), Nuclear Antigen |
|||
| MBS655143-1mg | MyBiosource | 1mg | 825 EUR |
Epstein Barr Virus (EBV), Nuclear Antigen |
|||
| MBS655143-5x1mg | MyBiosource | 5x1mg | 3480 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) |
|||
| MBS624641-1mL | MyBiosource | 1mL | 1000 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) |
|||
| MBS624641-5x1mL | MyBiosource | 5x1mL | 4345 EUR |
Epstein Barr Virus Antibody (capsid antigen p120) |
|||
| GWB-52297C | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus, Nuclear Antigen (EBV) (AP) |
|||
| MBS6474718-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (AP) |
|||
| MBS6474718-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (PE) |
|||
| MBS6474723-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (PE) |
|||
| MBS6474723-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (APC) |
|||
| MBS6474719-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (APC) |
|||
| MBS6474719-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (HRP) |
|||
| MBS6474722-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (HRP) |
|||
| MBS6474722-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus Antibody (early nuclear antigen) |
|||
| GWB-Q00933 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus, Nuclear Antigen (EBV) (FITC) |
|||
| MBS6474721-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (FITC) |
|||
| MBS6474721-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus Antibody (nuclear antigen) (Biotin) |
|||
| GWB-40A338 | GenWay Biotech | 1 ml | Ask for price |
Epstein Barr Virus, Nuclear Antigen (EBV) (Biotin) |
|||
| MBS6474720-01mL | MyBiosource | 0.1mL | 1280 EUR |
Epstein Barr Virus, Nuclear Antigen (EBV) (Biotin) |
|||
| MBS6474720-5x01mL | MyBiosource | 5x0.1mL | 5605 EUR |
Epstein Barr Virus Viral Capsid Antigen Biotin |
|||
| MBS6120656-01mL | MyBiosource | 0.1(mL | 860 EUR |
Epstein Barr Virus Viral Capsid Antigen Biotin |
|||
| MBS6120656-5x01mL | MyBiosource | 5x0.1mL | 3725 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (AP) |
|||
| MBS6260155-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (AP) |
|||
| MBS6260155-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (PE) |
|||
| MBS6262706-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (PE) |
|||
| MBS6262706-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (HRP) |
|||
| MBS6262196-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (HRP) |
|||
| MBS6262196-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (APC) |
|||
| MBS6260666-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (APC) |
|||
| MBS6260666-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (FITC) |
|||
| MBS6261686-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (FITC) |
|||
| MBS6261686-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus Antibody |
|||
| GWB-378AD4 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus Antibody |
|||
| GWB-243340 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus Antibody |
|||
| GWB-C4E88B | GenWay Biotech | 0.1 mg | Ask for price |
Epstein Barr Virus (EBV), Viral Capsid Antigen, P3HR1 |
|||
| MBS655113-1mg | MyBiosource | 1mg | 800 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, P3HR1 |
|||
| MBS655113-5x1mg | MyBiosource | 5x1mg | 3370 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (Biotin) |
|||
| MBS6261177-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (Biotin) |
|||
| MBS6261177-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (AP) |
|||
| MBS6241674-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (AP) |
|||
| MBS6241674-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (PE) |
|||
| MBS6244338-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (PE) |
|||
| MBS6244338-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (AP) |
|||
| MBS6260156-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (AP) |
|||
| MBS6260156-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (PE) |
|||
| MBS6262707-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (PE) |
|||
| MBS6262707-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (AP) |
|||
| MBS6126140-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (AP) |
|||
| MBS6126140-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (PE) |
|||
| MBS6129234-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (PE) |
|||
| MBS6129234-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (HRP) |
|||
| MBS6243805-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (HRP) |
|||
| MBS6243805-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (APC) |
|||
| MBS6242207-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (APC) |
|||
| MBS6242207-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (HRP) |
|||
| MBS6262197-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (HRP) |
|||
| MBS6262197-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (APC) |
|||
| MBS6260667-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (APC) |
|||
| MBS6260667-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (HRP) |
|||
| MBS6128613-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (HRP) |
|||
| MBS6128613-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (APC) |
|||
| MBS6126758-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (APC) |
|||
| MBS6126758-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV) |
|||
| MBS636498-01mg | MyBiosource | 0.1mg | 540 EUR |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV) |
|||
| MBS636498-5x01mg | MyBiosource | 5x0.1mg | 2275 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (FITC) |
|||
| MBS6243272-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (FITC) |
|||
| MBS6243272-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (FITC) |
|||
| MBS6261687-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (FITC) |
|||
| MBS6261687-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (FITC) |
|||
| MBS6127997-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (FITC) |
|||
| MBS6127997-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus (EBV) |
|||
| GWB-BCFC81 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus (EBV) |
|||
| MBS655263-1mg | MyBiosource | 1mg | 825 EUR |
Epstein Barr Virus (EBV) |
|||
| MBS655263-5x1mg | MyBiosource | 5x1mg | 3480 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 490) |
|||
| MBS6263728-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 490) |
|||
| MBS6263728-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 550) |
|||
| MBS6264239-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 550) |
|||
| MBS6264239-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 650) |
|||
| MBS6264750-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 650) |
|||
| MBS6264750-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 750) |
|||
| MBS6265261-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 750) |
|||
| MBS6265261-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 405) |
|||
| MBS6263217-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen (MaxLight 405) |
|||
| MBS6263217-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (Biotin) |
|||
| MBS6242740-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (Biotin) |
|||
| MBS6242740-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (Biotin) |
|||
| MBS6261178-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (Biotin) |
|||
| MBS6261178-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus Antibody (LMP) |
|||
| GWB-1DCE8E | GenWay Biotech | 1 ml | Ask for price |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (Biotin) |
|||
| MBS6127378-01mL | MyBiosource | 0.1(mL | 1150 EUR |
Epstein Barr Virus (EBV), Viral Capsid Antigen, gp125 (Biotin) |
|||
| MBS6127378-5x01mL | MyBiosource | 5x0.1mL | 5025 EUR |
Epstein Barr Virus, Early Antigen, Restricted, Bcl 2 (EA) (EBV) |
|||
| MBS604213-01mg | MyBiosource | 0.1mg | 580 EUR |
Epstein Barr Virus, Early Antigen, Restricted, Bcl 2 (EA) (EBV) |
|||
| MBS604213-5x01mg | MyBiosource | 5x0.1mg | 2470 EUR |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-5378B2 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-83E7C8 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-91C835 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-949360 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-B44091 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) |
|||
| MBS601335-01mg | MyBiosource | 0.1mg | 655 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) |
|||
| MBS601335-5x01mg | MyBiosource | 5x0.1mg | 2795 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) |
|||
| MBS609692-01mg | MyBiosource | 0.1mg | 580 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) |
|||
| MBS609692-5x01mg | MyBiosource | 5x0.1mg | 2470 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 405) |
|||
| MBS6244871-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 405) |
|||
| MBS6244871-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 490) |
|||
| MBS6245404-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 490) |
|||
| MBS6245404-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 750) |
|||
| MBS6247003-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 750) |
|||
| MBS6247003-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 550) |
|||
| MBS6245937-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 550) |
|||
| MBS6245937-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 650) |
|||
| MBS6246470-01mL | MyBiosource | 0.1(mL | 925 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 650) |
|||
| MBS6246470-5x01mL | MyBiosource | 5x0.1mL | 4020 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 490) |
|||
| MBS6263729-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 490) |
|||
| MBS6263729-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 550) |
|||
| MBS6264240-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 550) |
|||
| MBS6264240-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 650) |
|||
| MBS6264751-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 650) |
|||
| MBS6264751-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 750) |
|||
| MBS6265262-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 750) |
|||
| MBS6265262-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 405) |
|||
| MBS6263218-01mL | MyBiosource | 0.1mL | 785 EUR |
Epstein Barr Virus (EBV), Early Antigen, Diffuse, p52,50 (MaxLight 405) |
|||
| MBS6263218-5x01mL | MyBiosource | 5x0.1mL | 3380 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310152-1mg | MyBiosource | 1mg | 1270 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310152-5x1mg | MyBiosource | 5x1mg | 5550 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310154-1mg | MyBiosource | 1mg | 1270 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310154-5x1mg | MyBiosource | 5x1mg | 5550 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310209-1mg | MyBiosource | 1mg | 1270 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310209-5x1mg | MyBiosource | 5x1mg | 5550 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310210-01mg | MyBiosource | 0.1mg | 640 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310210-5x01mg | MyBiosource | 5x0.1mg | 2715 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310341-1mg | MyBiosource | 1mg | 670 EUR |
MAb to Epstein Barr Virus |
|||
| MBS310341-5x1mg | MyBiosource | 5x1mg | 2835 EUR |
Epstein Barr Virus (VCA) IgM |
|||
| GWB-F67BD1 | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus (VCA) IgG |
|||
| GWB-F14231 | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus, LMP-1 |
|||
| MBS370066-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (FITC) |
|||
| MBS6249845-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (FITC) |
|||
| MBS6249845-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (HRP) |
|||
| MBS6250841-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (HRP) |
|||
| MBS6250841-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (AP) |
|||
| MBS6247899-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (AP) |
|||
| MBS6247899-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (PE) |
|||
| MBS6251794-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (PE) |
|||
| MBS6251794-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (APC) |
|||
| MBS6268752-01mL | MyBiosource | 0.1mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (APC) |
|||
| MBS6268752-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus (EBNA) IgG |
|||
| GWB-5ED61E | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus (EBV-VCA) |
|||
| GWB-A7992B | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus Monoclonal Antibody |
|||
| MBS190144-01mg | MyBiosource | 0.1mg | 315 EUR |
Epstein Barr Virus Monoclonal Antibody |
|||
| MBS190145-01mg | MyBiosource | 0.1mg | 315 EUR |
Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV) |
|||
| MBS636094-01mg | MyBiosource | 0.1mg | 755 EUR |
Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV) |
|||
| MBS636094-5x01mg | MyBiosource | 5x0.1mg | 3170 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (Biotin) |
|||
| MBS6248920-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (Biotin) |
|||
| MBS6248920-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (AP) |
|||
| MBS6241675-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (AP) |
|||
| MBS6241675-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (PE) |
|||
| MBS6244339-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (PE) |
|||
| MBS6244339-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein-Barr virus Epstein-Barr nuclear antigen 2 (EBNA2) |
|||
| 1-CSB-YP718162EEZ(A4) | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 2(EBNA2),partial expressed in Yeast |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 1 (EBNA1) |
|||
| 1-CSB-EP365878EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 1(EBNA1),partial expressed in E.coli |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3) |
|||
| 1-CSB-EP319032EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3),partial expressed in E.coli |
|||
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (HRP) |
|||
| MBS6243806-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (HRP) |
|||
| MBS6243806-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (APC) |
|||
| MBS6242208-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (APC) |
|||
| MBS6242208-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (FITC) |
|||
| MBS6243273-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (FITC) |
|||
| MBS6243273-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 490) |
|||
| MBS6253847-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 490) |
|||
| MBS6253847-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 550) |
|||
| MBS6254887-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 550) |
|||
| MBS6254887-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 405) |
|||
| MBS6252807-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 405) |
|||
| MBS6252807-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 750) |
|||
| MBS6256966-01mL | MyBiosource | 0.1mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 750) |
|||
| MBS6256966-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 650) |
|||
| MBS6255927-01mL | MyBiosource | 0.1(mL | 865 EUR |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) (MaxLight 650) |
|||
| MBS6255927-5x01mL | MyBiosource | 5x0.1mL | 3750 EUR |
Epstein Barr Virus (EBNA-nuclear) |
|||
| GWB-2F10DC | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (Biotin) |
|||
| MBS6242741-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (Biotin) |
|||
| MBS6242741-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus (EBV) EBNA, Antibody |
|||
| GWB-53FBAA | GenWay Biotech | 0.2 mg | Ask for price |
OAMA00189-1MG - Epstein Barr Virus Antibody |
|||
| OAMA00189-1MG | Aviva Systems Biology | 1mg | 1249 EUR |
OAMA00352-1MG - Epstein Barr Virus Antibody |
|||
| OAMA00352-1MG | Aviva Systems Biology | 1mg | 599 EUR |
Epstein Barr Virus / EBV Nuclear Antigen goat polyclonal antibody, Purified |
|||
| AP00695PU-N | Origene Technologies GmbH | 1 ml | Ask for price |
Recombinant Epstein Barr Virus (HHV-4) Early Antigen D, GST-tagged |
|||
| DAG543 | Creative Diagnostics | 1mg | 1632 EUR |
Epstein Barr Virus, env gp (EBV) |
|||
| MBS603798-02mg | MyBiosource | 0.2mg | 535 EUR |
Epstein Barr Virus, env gp (EBV) |
|||
| MBS603798-5x02mg | MyBiosource | 5x0.2mg | 2255 EUR |
Epstein-Barr Virus (EBV) Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1), Recombinant |
|||
| MBS313443-1mg | MyBiosource | 1mg | 1635 EUR |
Epstein-Barr Virus (EBV) Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1), Recombinant |
|||
| MBS313443-5x1mg | MyBiosource | 5x1mg | 7120 EUR |
Epstein Barr Virus (EBV), gp250/350 |
|||
| MBS6507448-01mg | MyBiosource | 0.1mg | 710 EUR |
Epstein Barr Virus (EBV), gp250/350 |
|||
| MBS6507448-5x01mg | MyBiosource | 5x0.1mg | 3040 EUR |
Epstein Barr Virus (EBV) EA-early |
|||
| GWB-89FE90 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus gp125, Mouse Fc |
|||
| REC31601-100 | The Native Antigen Company | 0.1 | 517.95 EUR |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
|||
Epstein Barr Virus gp125, Mouse Fc |
|||
| REC31601-500 | The Native Antigen Company | 0.5 | 1852.39 EUR |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
|||
Epstein Barr Virus gp125, Human Fc |
|||
| REC31602-100 | The Native Antigen Company | 0.1 | 517.95 EUR |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
|||
Epstein Barr Virus gp125, Human Fc |
|||
| REC31602-500 | The Native Antigen Company | 0.5 | 1852.39 EUR |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
|||
Epstein Barr Virus, (EBV) Antibody, Concentrate |
|||
| MAB875C | Innovex | 0.2ml | 425 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 405) |
|||
| MBS6244872-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 405) |
|||
| MBS6244872-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 490) |
|||
| MBS6245405-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 490) |
|||
| MBS6245405-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 750) |
|||
| MBS6247004-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 750) |
|||
| MBS6247004-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 550) |
|||
| MBS6245938-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 550) |
|||
| MBS6245938-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 650) |
|||
| MBS6246471-01mL | MyBiosource | 0.1(mL | 945 EUR |
Epstein Barr Virus, Early Antigen, Restricted p17, Bc12 (EA) (EBV) (MaxLight 650) |
|||
| MBS6246471-5x01mL | MyBiosource | 5x0.1mL | 4095 EUR |
Epstein Barr Virus (EBV) EA-D, Antibody |
|||
| GWB-9B31A2 | GenWay Biotech | 0.2 mg | Ask for price |
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 2 (EBNA2) |
|||
| MBS1180742-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1090 EUR |
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 2 (EBNA2) |
|||
| MBS1180742-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 680 EUR |
All prototype vaccines conferred safety from viral problem an infection and the multivalent presentation of the chosen antigens on the MPSP markedly improved their immunogenicity in comparison with the monomeric subunits. Even a single shot vaccination protected about 80% of mice from an in any other case deadly dose of SBV. Most importantly, the MPSPs induced a nearly sterile immunity in cattle. Altogether, LS represents a promising platform for modular and speedy vaccine design.